UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ANAPC5-LTA4H |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ANAPC5-LTA4H | FusionPDB ID: 4300 | FusionGDB2.0 ID: 4300 | Hgene | Tgene | Gene symbol | ANAPC5 | LTA4H | Gene ID | 51433 | 4048 |
Gene name | anaphase promoting complex subunit 5 | leukotriene A4 hydrolase | |
Synonyms | APC5 | - | |
Cytomap | 12q24.31 | 12q23.1 | |
Type of gene | protein-coding | protein-coding | |
Description | anaphase-promoting complex subunit 5cyclosome subunit 5 | leukotriene A-4 hydrolaseLTA-4 hydrolasetesticular secretory protein Li 27 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9UJX4 | P09960 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000261819, ENST00000344395, ENST00000441917, ENST00000535482, ENST00000541887, ENST00000544314, ENST00000536366, | ENST00000548375, ENST00000228740, ENST00000413268, ENST00000552789, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 9 X 11 X 6=594 | 9 X 9 X 6=486 |
# samples | 11 | 8 | |
** MAII score | log2(11/594*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/486*10)=-2.60288440871842 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ANAPC5 [Title/Abstract] AND LTA4H [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ANAPC5(121756080)-LTA4H(96402926), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ANAPC5-LTA4H seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ANAPC5-LTA4H seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ANAPC5-LTA4H seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ANAPC5-LTA4H seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ANAPC5-LTA4H seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. ANAPC5-LTA4H seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. ANAPC5-LTA4H seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ANAPC5 | GO:0070979 | protein K11-linked ubiquitination | 18485873 |
Tgene | LTA4H | GO:0019370 | leukotriene biosynthetic process | 9774412|15078870 |
Tgene | LTA4H | GO:0043171 | peptide catabolic process | 9774412|15078870|18804029 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-DX-A3LS-01A | ANAPC5 | chr12 | 121756080 | - | LTA4H | chr12 | 96402926 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000441917 | ANAPC5 | chr12 | 121756080 | - | ENST00000228740 | LTA4H | chr12 | 96402926 | - | 2267 | 1649 | 17 | 1654 | 545 |
ENST00000441917 | ANAPC5 | chr12 | 121756080 | - | ENST00000552789 | LTA4H | chr12 | 96402926 | - | 2265 | 1649 | 17 | 1654 | 545 |
ENST00000441917 | ANAPC5 | chr12 | 121756080 | - | ENST00000413268 | LTA4H | chr12 | 96402926 | - | 2105 | 1649 | 17 | 1654 | 545 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000441917 | ENST00000228740 | ANAPC5 | chr12 | 121756080 | - | LTA4H | chr12 | 96402926 | - | 0.002518749 | 0.9974813 |
ENST00000441917 | ENST00000552789 | ANAPC5 | chr12 | 121756080 | - | LTA4H | chr12 | 96402926 | - | 0.002530663 | 0.9974693 |
ENST00000441917 | ENST00000413268 | ANAPC5 | chr12 | 121756080 | - | LTA4H | chr12 | 96402926 | - | 0.003554512 | 0.9964455 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >4300_4300_1_ANAPC5-LTA4H_ANAPC5_chr12_121756080_ENST00000441917_LTA4H_chr12_96402926_ENST00000228740_length(amino acids)=545AA_BP= MSKLYKLIEESCPQLANSVQIRIKLMAEGELKDMEQFFDDLSDSFSGTEPEVHKTSVVGLFLRHMILAYSKLSFSQVFKLYTALQQYFQN GEKKTVEDADMELTSRDEGERKMEKEELDVSVREEEVSCSGPLSQKQAEFFLSQQASLLKNDETKALTPASLQKELNNLLKFNPDFAEAH YLSYLNNLRVQDVFSSTHSLLHYFDRLILTGAESKSNGEEGYGRSLRYAALNLAALHCRFGHYQQAELALQEAIRIAQESNDHVCLQHCL SWLYVLGQKRSDSYVLLEHSVKKAVHFGLPRAFAGKTANKLMDALKDSDLLHWKHSLSELIDISIAQKTAIWRLYGRSTMALQQAQMLLS MNSLEAVNAGVQQNNTESFAVALCHLAELHAEQGCFAAASEVLKHLKERFPPNSQHAQLWMLCDQKIQFDRAMNDGKYHLADSLVTGITA LNSIEGVYRKAVVLQAQNQMSEAHKLLQKLLVHCQKLKNTEMVISVLLSVAELYWRSSSPTIALPMLLQALALSKEYRLQYLASETVLNL -------------------------------------------------------------- >4300_4300_2_ANAPC5-LTA4H_ANAPC5_chr12_121756080_ENST00000441917_LTA4H_chr12_96402926_ENST00000413268_length(amino acids)=545AA_BP= MSKLYKLIEESCPQLANSVQIRIKLMAEGELKDMEQFFDDLSDSFSGTEPEVHKTSVVGLFLRHMILAYSKLSFSQVFKLYTALQQYFQN GEKKTVEDADMELTSRDEGERKMEKEELDVSVREEEVSCSGPLSQKQAEFFLSQQASLLKNDETKALTPASLQKELNNLLKFNPDFAEAH YLSYLNNLRVQDVFSSTHSLLHYFDRLILTGAESKSNGEEGYGRSLRYAALNLAALHCRFGHYQQAELALQEAIRIAQESNDHVCLQHCL SWLYVLGQKRSDSYVLLEHSVKKAVHFGLPRAFAGKTANKLMDALKDSDLLHWKHSLSELIDISIAQKTAIWRLYGRSTMALQQAQMLLS MNSLEAVNAGVQQNNTESFAVALCHLAELHAEQGCFAAASEVLKHLKERFPPNSQHAQLWMLCDQKIQFDRAMNDGKYHLADSLVTGITA LNSIEGVYRKAVVLQAQNQMSEAHKLLQKLLVHCQKLKNTEMVISVLLSVAELYWRSSSPTIALPMLLQALALSKEYRLQYLASETVLNL -------------------------------------------------------------- >4300_4300_3_ANAPC5-LTA4H_ANAPC5_chr12_121756080_ENST00000441917_LTA4H_chr12_96402926_ENST00000552789_length(amino acids)=545AA_BP= MSKLYKLIEESCPQLANSVQIRIKLMAEGELKDMEQFFDDLSDSFSGTEPEVHKTSVVGLFLRHMILAYSKLSFSQVFKLYTALQQYFQN GEKKTVEDADMELTSRDEGERKMEKEELDVSVREEEVSCSGPLSQKQAEFFLSQQASLLKNDETKALTPASLQKELNNLLKFNPDFAEAH YLSYLNNLRVQDVFSSTHSLLHYFDRLILTGAESKSNGEEGYGRSLRYAALNLAALHCRFGHYQQAELALQEAIRIAQESNDHVCLQHCL SWLYVLGQKRSDSYVLLEHSVKKAVHFGLPRAFAGKTANKLMDALKDSDLLHWKHSLSELIDISIAQKTAIWRLYGRSTMALQQAQMLLS MNSLEAVNAGVQQNNTESFAVALCHLAELHAEQGCFAAASEVLKHLKERFPPNSQHAQLWMLCDQKIQFDRAMNDGKYHLADSLVTGITA LNSIEGVYRKAVVLQAQNQMSEAHKLLQKLLVHCQKLKNTEMVISVLLSVAELYWRSSSPTIALPMLLQALALSKEYRLQYLASETVLNL -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:121756080/chr12:96402926) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ANAPC5 | LTA4H |
FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. {ECO:0000269|PubMed:18485873}. | FUNCTION: Bifunctional zinc metalloenzyme that comprises both epoxide hydrolase (EH) and aminopeptidase activities. Acts as an epoxide hydrolase to catalyze the conversion of LTA4 to the proinflammatory mediator leukotriene B4 (LTB4) (PubMed:11917124, PubMed:12207002, PubMed:15078870, PubMed:18804029, PubMed:1897988, PubMed:1975494, PubMed:2244921). Has also aminopeptidase activity, with high affinity for N-terminal arginines of various synthetic tripeptides (PubMed:20813919, PubMed:18804029). In addition to its proinflammatory EH activity, may also counteract inflammation by its aminopeptidase activity, which inactivates by cleavage another neutrophil attractant, the tripeptide Pro-Gly-Pro (PGP), a bioactive fragment of collagen generated by the action of matrix metalloproteinase-9 (MMP9) and prolylendopeptidase (PREPL) (PubMed:20813919, PubMed:24591641). Involved also in the biosynthesis of resolvin E1 and 18S-resolvin E1 from eicosapentaenoic acid, two lipid mediators that show potent anti-inflammatory and pro-resolving actions (PubMed:21206090). {ECO:0000269|PubMed:11917124, ECO:0000269|PubMed:12207002, ECO:0000269|PubMed:15078870, ECO:0000269|PubMed:18804029, ECO:0000269|PubMed:1897988, ECO:0000269|PubMed:1975494, ECO:0000269|PubMed:20813919, ECO:0000269|PubMed:21206090, ECO:0000269|PubMed:2244921, ECO:0000269|PubMed:24591641}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 209_249 | 631.0 | 756.0 | Repeat | Note=TPR 1 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 250_300 | 631.0 | 756.0 | Repeat | Note=TPR 2 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 301_337 | 631.0 | 756.0 | Repeat | Note=TPR 3 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 338_378 | 631.0 | 756.0 | Repeat | Note=TPR 4 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 379_418 | 631.0 | 756.0 | Repeat | Note=TPR 5 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 419_466 | 631.0 | 756.0 | Repeat | Note=TPR 6 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 467_500 | 631.0 | 756.0 | Repeat | Note=TPR 7 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 501_540 | 631.0 | 756.0 | Repeat | Note=TPR 8 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 541_580 | 631.0 | 756.0 | Repeat | Note=TPR 9 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 581_620 | 631.0 | 756.0 | Repeat | Note=TPR 10 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 209_249 | 519.0 | 644.0 | Repeat | Note=TPR 1 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 250_300 | 519.0 | 644.0 | Repeat | Note=TPR 2 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 301_337 | 519.0 | 644.0 | Repeat | Note=TPR 3 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 338_378 | 519.0 | 644.0 | Repeat | Note=TPR 4 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 379_418 | 519.0 | 644.0 | Repeat | Note=TPR 5 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 419_466 | 519.0 | 644.0 | Repeat | Note=TPR 6 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 467_500 | 519.0 | 644.0 | Repeat | Note=TPR 7 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 209_249 | 519.0 | 644.0 | Repeat | Note=TPR 1 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 250_300 | 519.0 | 644.0 | Repeat | Note=TPR 2 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 301_337 | 519.0 | 644.0 | Repeat | Note=TPR 3 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 338_378 | 519.0 | 644.0 | Repeat | Note=TPR 4 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 379_418 | 519.0 | 644.0 | Repeat | Note=TPR 5 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 419_466 | 519.0 | 644.0 | Repeat | Note=TPR 6 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 467_500 | 519.0 | 644.0 | Repeat | Note=TPR 7 |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000228740 | 13 | 19 | 564_566 | 459.6666666666667 | 612.0 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000413268 | 13 | 18 | 564_566 | 435.6666666666667 | 489.6666666666667 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000552789 | 13 | 19 | 564_566 | 435.6666666666667 | 588.0 | Region | Substrate binding |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 621_660 | 631.0 | 756.0 | Repeat | Note=TPR 11 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 661_696 | 631.0 | 756.0 | Repeat | Note=TPR 12 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000261819 | - | 15 | 17 | 697_736 | 631.0 | 756.0 | Repeat | Note=TPR 13 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 501_540 | 519.0 | 644.0 | Repeat | Note=TPR 8 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 541_580 | 519.0 | 644.0 | Repeat | Note=TPR 9 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 581_620 | 519.0 | 644.0 | Repeat | Note=TPR 10 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 621_660 | 519.0 | 644.0 | Repeat | Note=TPR 11 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 661_696 | 519.0 | 644.0 | Repeat | Note=TPR 12 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000344395 | - | 13 | 15 | 697_736 | 519.0 | 644.0 | Repeat | Note=TPR 13 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 501_540 | 519.0 | 644.0 | Repeat | Note=TPR 8 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 541_580 | 519.0 | 644.0 | Repeat | Note=TPR 9 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 581_620 | 519.0 | 644.0 | Repeat | Note=TPR 10 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 621_660 | 519.0 | 644.0 | Repeat | Note=TPR 11 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 661_696 | 519.0 | 644.0 | Repeat | Note=TPR 12 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000441917 | - | 14 | 16 | 697_736 | 519.0 | 644.0 | Repeat | Note=TPR 13 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 209_249 | 0.0 | 220.0 | Repeat | Note=TPR 1 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 250_300 | 0.0 | 220.0 | Repeat | Note=TPR 2 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 301_337 | 0.0 | 220.0 | Repeat | Note=TPR 3 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 338_378 | 0.0 | 220.0 | Repeat | Note=TPR 4 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 379_418 | 0.0 | 220.0 | Repeat | Note=TPR 5 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 419_466 | 0.0 | 220.0 | Repeat | Note=TPR 6 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 467_500 | 0.0 | 220.0 | Repeat | Note=TPR 7 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 501_540 | 0.0 | 220.0 | Repeat | Note=TPR 8 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 541_580 | 0.0 | 220.0 | Repeat | Note=TPR 9 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 581_620 | 0.0 | 220.0 | Repeat | Note=TPR 10 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 621_660 | 0.0 | 220.0 | Repeat | Note=TPR 11 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 661_696 | 0.0 | 220.0 | Repeat | Note=TPR 12 |
Hgene | ANAPC5 | chr12:121756080 | chr12:96402926 | ENST00000536366 | - | 1 | 5 | 697_736 | 0.0 | 220.0 | Repeat | Note=TPR 13 |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000228740 | 13 | 19 | 135_137 | 459.6666666666667 | 612.0 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000228740 | 13 | 19 | 267_272 | 459.6666666666667 | 612.0 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000228740 | 13 | 19 | 362_365 | 459.6666666666667 | 612.0 | Region | Inhibitor ARM1 binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000413268 | 13 | 18 | 135_137 | 435.6666666666667 | 489.6666666666667 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000413268 | 13 | 18 | 267_272 | 435.6666666666667 | 489.6666666666667 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000413268 | 13 | 18 | 362_365 | 435.6666666666667 | 489.6666666666667 | Region | Inhibitor ARM1 binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000552789 | 13 | 19 | 135_137 | 435.6666666666667 | 588.0 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000552789 | 13 | 19 | 267_272 | 435.6666666666667 | 588.0 | Region | Substrate binding | |
Tgene | LTA4H | chr12:121756080 | chr12:96402926 | ENST00000552789 | 13 | 19 | 362_365 | 435.6666666666667 | 588.0 | Region | Inhibitor ARM1 binding |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ANAPC5 | |
LTA4H |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ANAPC5-LTA4H |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ANAPC5-LTA4H |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |